These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38916730)

  • 1. Nogo-A Drives Alzheimer's Disease Progression by Inducing Tauopathy Vulnerability.
    Wang Z; Pan JP; Geng J; Lv S; Chen G; Fang N; Zhang Z; Li J; Xu X; Wang R; Zheng Q; Yan L; Chen G; Xiao F
    Aging Dis; 2024 May; ():. PubMed ID: 38916730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
    Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
    Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
    Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
    Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHCR24 Knockdown Lead to Hyperphosphorylation of Tau at Thr181, Thr231, Ser262, Ser396, and Ser422 Sites by Membrane Lipid-Raft Dependent PP2A Signaling in SH-SY5Y Cells.
    Qi Z; Zhang Y; Yao K; Zhang M; Xu Y; Zhang J; Bai X; Zu H
    Neurochem Res; 2021 Jul; 46(7):1627-1640. PubMed ID: 33710538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy.
    Alavi Naini SM; Yanicostas C; Hassan-Abdi R; Blondeel S; Bennis M; Weiss RJ; Tor Y; Esko JD; Soussi-Yanicostas N
    Transl Neurodegener; 2018; 7():6. PubMed ID: 29568517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.
    Zhu H; Zhang W; Zhao Y; Shu X; Wang W; Wang D; Yang Y; He Z; Wang X; Ying Y
    Mol Neurodegener; 2018 Nov; 13(1):62. PubMed ID: 30466464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signaling.
    Bai X; Wu J; Zhang M; Xu Y; Duan L; Yao K; Zhang J; Bo J; Zhao Y; Xu G; Zu H
    Front Aging Neurosci; 2021; 13():513605. PubMed ID: 33967735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptotanshinone Attenuates Amyloid-β
    Lyu D; Jia J
    Mol Neurobiol; 2022 Jul; 59(7):4488-4500. PubMed ID: 35575872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation.
    Zhao D; Zhou Y; Huo Y; Meng J; Xiao X; Han L; Zhang X; Luo H; Can D; Sun H; Huang TY; Wang X; Zhang J; Liu FR; Xu H; Zhang YW
    Cell Death Differ; 2021 Jan; 28(1):337-348. PubMed ID: 32908202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
    Zaki MO; El-Desouky S; Elsherbiny DA; Salama M; Azab SS
    Inflammopharmacology; 2022 Oct; 30(5):1871-1890. PubMed ID: 35922737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer's disease and tauopathy models.
    Selvarasu K; Singh AK; Iyaswamy A; Gopalkrishnashetty Sreenivasmurthy S; Krishnamoorthi S; Bera AK; Huang JD; Durairajan SSK
    Front Mol Biosci; 2022; 9():1050768. PubMed ID: 36387285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice.
    Zuo Y; Liu HT; Lin LB; Yue RZ; Liu HH; Wang HW; Wang L; Hou RL; Liu WZ; Li CZ; Wang JZ; Li P; Yin YL
    Exp Neurol; 2024 Mar; 373():114657. PubMed ID: 38141802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
    Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
    PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.
    Emmerson JT; Malcolm JC; Do Carmo S; Nguyen P; Breuillaud L; Martinez-Trujillo JC; Cuello AC
    Neurobiol Dis; 2023 Oct; 187():106317. PubMed ID: 37802153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.